Gsk Share Discussion Threads

[essentialinvestor] 18/8/2022 15:17

As harsh as the US judicial system can be for non US companies, they do don't usually seek to bankrupt corporates - if there are large amounts to be paid out,
which is far from certain.

The only big exception I can think of is asbestos law suits,
which destroyed many companies.

LSE listed SMIN is one of the survivors and is still dealing with annual asbestos claims all these years later.

[my retirement fund] 18/8/2022 15:03

Couldn't resist £14 so dipped toe in

[netcurtains] 18/8/2022 12:38

AZN gone blue....

Its about time GSK followed.

[tradermichael] 18/8/2022 11:42

So, let's hope that they can handle a massive production program.

[berny3] 18/8/2022 11:02

Jonjonell, that is really interesting thank you. in 2020 there were 241mln cases of malaria world wide. with 95% of cases in Africa.



18mln doses is a drop in the ocean and the potential for upside in this vaccine is equal to if not more than the shingles vaccine in China.

[jonjoneil] 18/8/2022 10:23

GSK lands first-ever UNICEF contract for malaria vaccine

[tuftymatt] 18/8/2022 08:54

Hey net, my choice of words was poor and I should have said something like "and it's clear GSK and others will defend these unfounded accusations if necessary."

Agree it's easy to file cases but far harder to win them.

[netcurtains] 18/8/2022 07:34

It doesn't appear if GSK needs to fight. The "no win no fee" type law would not have bothered dropping out unless it was a totally hopeless case. It's pretty clear GSK is now in the clear from all legal cases relating to the DERIVATIVE versions of Zantac..... And probably in the clear from the real Zantac too.

[tuftymatt] 18/8/2022 06:57

A fair write up and thanks una.

As well all know the market hates uncertainty so in this current climate it could drift lower in line with the general markets, excluding the obvious divi drop.

I would not expect any significant drop though as the news is now out there in my opinion and GSK and others will fight this hard.

[unastubbs] 18/8/2022 06:52

also this in The Times today offers some insight in to the story yesterday about the first case being withdrawn

"Shares in Haleon fell to fresh lows and GSK, which spun the company off last month, weakened over concerns about potential liabilities relating to Zantac after a report that generic drug companies had reached a settlement in a US legal case (Alex Ralph writes). It emerged on Tuesday that the plaintiff in the first lawsuit due to go to trial in Illinois had dropped his case. GSK, a defendant in the case, welcomed the decision. A lawyer for the claimant, however, said her client had decided not to pursue the case at this time because of complications from the removal of his oesophagus. Bloomberg reported that generic drugmakers Teva, Perrigo, Sun Pharma and Dr Reddy's Laboratories agreed to a combined settlement of more than $500,000 with the claimant after he alleged Zantac, a medication for heartburn, caused his oesophageal cancer. Haleon, the former consumer healthcare joint venture of GSK and Pfizer, has said it is not a party to any Zantac claims and conditions would need to be met before it was required to indemnify GSK and Pfizer of any liabilities. Haleon closed down 10¾p at 258½p and GSK fell 9½p to £14.15½p."

[unastubbs] 18/8/2022 06:47

Shares Magazine today on the situation

[redbaron10] 18/8/2022 00:37

How about 1390.6? No idea, but somebody has to take up the challenge!!

[jonjoneil] 17/8/2022 16:32

Any guesses on opening price tomorrow. If the price discounts the dividend, I will use that as my reentry point. Otherwise I will continue monitoring from the sidelines.
I sold on a whim (coin toss), and I will use equal vaguery to get back in. The longer I try to reason my way back the longer I will stay out.

[wallywoo] 17/8/2022 15:13

There's no cut in dividend 56.5 to 65p per annum. Around 4.65% yield.


There are better yields out there but when you consider how defensive this sector is, I am happy with this yield. Personally expect choppy markets ahead.


Have loaded up here this week, average price Around 1405. Will hold for a while. Not worried about litigation risk at this price point- it's all in the price.

[tradermichael] 17/8/2022 14:35

GSK PLC said Wednesday that momelotinib's new drug application, or NDA, has been accepted by the U.S. Food and Drug Administration for the treatment of myelofibrosis.

The U.K. pharmaceutical company said the FDA assigned a Prescription Drug User Fee Act, or PDUFA, action date of June 16, 2023.

The PDUFA refers to the date by which the agency's review process must be completed.

The FTSE 100-listed company said the NDA is based on results from key Phase 3 trials which met all primary and key secondary endpoints, and added that momelotinib wasn't currently approved in any market.

[tradermichael] 17/8/2022 14:33

16.25p for Q2

[rikky72] 17/8/2022 14:33

Also topped up at £14.50 and £14 in last few days and tend to agree with NY boy although I'd hope for a recovery a little quicker than his timeframe :)It's a shame to see the poor sentiment from the days of old GSK carry over to new GSK. Yes, I would have expected a reaction to the litigation news (although I think the company's strong rebuttal plus absence of any real evidence augurs for a good outcome in the end) but the scale of it, to me anyway, tells me the investor community are still very negative on this company.They need a lot of things to go right over the next few years to change that but here's hoping.

[my retirement fund] 17/8/2022 14:16

So does anyone know what the forecast dividend yield is here now, presumably it will be cut, no?

[ny boy] 17/8/2022 13:48

Bought a chunk @ 14 for a long term hold, decent divi, the litigation seems a tad far fetched. This kind of stock you need to hold 5-20 years and forget about really, will check in this time next year on progress GL

[tradermichael] 17/8/2022 13:43

Serious undervaluation of my shares at present! Leadership squarely to blame for market perception of this company, especially when they could have off-loaded CH with a potentially game changing offer from Unilever.

[berny3] 17/8/2022 12:38

My view is this market move contains a disappointment in current leadership. That to me is sentiment and adds to my thoughts at this price the company is undervalued.

[berny3] 17/8/2022 12:16

Final tranche bought today. Fully invested back to my amount pre split.

[tradermichael] 17/8/2022 11:34

GSK xdiv tomorrow, 16.25p per share

[porsche1945] 17/8/2022 11:31

Gsk are the originators of this drug. Spells big trouble. Osteoporosis also linked to this drug as it blocks calcium absorption. 10 years plus fighting this in US courts, dire, still a load of debt too and shyte management. Poor suckers who bought haleon too. Buy US, UK shares like the brexit basket case U.K. itself, totally fxcked.